Status:
COMPLETED
The Genetics of Severe Asthma in Children
Lead Sponsor:
Connecticut Children's Medical Center
Collaborating Sponsors:
UConn Health
Conditions:
Asthma
Eligibility:
All Genders
4-18 years
Brief Summary
Near fatal asthma exacerbations are one of the most common causes of critical illness in children, accounting for approximately ten thousand intensive care unit (ICU) admissions per year in the United...
Detailed Description
Our primary outcome measure is the development of a near fatal asthma exacerbation. Secondary outcome measures will include the duration of continuously nebulized ADRβ2 agonist therapy and the duratio...
Eligibility Criteria
Inclusion
- Inclusion Criteria, inpatient asthmatics:
- Admission to study institution with a primary admission diagnosis of asthma exacerbation
- Age between 4 and 18 years
- Exclusion Criteria, inpatient asthmatics:
- \- Pre-existing chronic disease (other than asthma), including: i. bronchopulmonary dysplasia ii. bronchomalacia iii. tracheomalacia iv. laryngomalacia v. vocal cord dysfunction vi. chronic restrictive lung disease vii. recurrent aspiration pneumonia viii. impaired mucous clearance ix. congenital heart disease x. pulmonary hypertension
- Inclusion Criteria, outpatient asthmatics:
- Diagnosis of asthma
- Age between 4 and 18 years
- Exclusion Criteria, outpatient asthmatics:
- Previous admission to the hospital for a near fatal asthma exacerbation
- Pre-existing chronic disease (other than asthma) including i. bronchopulmonary dysplasia ii. bronchomalacia iii. tracheomalacia iv. laryngomalacia v. vocal cord dysfunction vi. chronic restrictive lung disease vii. recurrent aspiration pneumonia viii. impaired mucous clearance ix. congenital heart disease x. pulmonary hypertension
- Inclusion Criteria, healthy controls:
- \- Age between 4 and 18 years
- Exclusion Criteria, healthy controls:
- \- Pre-existing chronic disease including: i. asthma ii. bronchopulmonary dysplasia iii. bronchomalacia iv. tracheomalacia v. laryngomalacia vi. vocal cord dysfunction vii. chronic restrictive lung disease viii. recurrent aspiration pneumonia ix. impaired mucous clearance x. congenital heart disease xi. pulmonary hypertension
Exclusion
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT01238432
Start Date
October 1 2009
End Date
April 1 2018
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06103